| Accession |
PRJCA011070 |
| Title |
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Efficacy and Safety Study of CBP-201 in Patients with Moderate to Severe Persistent Asthma with Type 2 Inflammation |
| Relevance |
Medical |
| Data types |
clinical data
|
| Organisms |
Homo sapiens
|
| Description |
This is a multicenter, randomized, double-blind, parallel group, placebo-controlled study to assess the efficacy and safety of two dose levels of CBP-201 in patients with moderate to severe persistent asthma with Type 2 inflammation. |
| Sample scope |
clinical testing data |
| Release date |
2022-08-08 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
yang
ting (dryangting@qq.com)
|
| Organization |
China-Japan Friendship Hospital |
| Submission date |
2022-08-08 |
